今すぐ寄付してください会員になる

カート (0)

DIAアカウントをお持ちの場合、サインインしてください。

サインイン

ユーザーIDをお忘れですか？ or パスワードをお忘れですか？

Not a Member?

アカウントを作成して参加。

Bethesda North Marriott Hotel and Conference Center

2018年10月02日 (火) 午前 7:00 - 2018年10月03日 (水) 午後 3:00

5701 Marinelli Road, , North Bethesda, MD 20852 , USA

Measuring Impact in Patient-Centered Drug Development Conference

戻る Agenda

Session 6: Approaches to Developing, Demonstrating, and Disseminating Metrics

Session Chair(s)

Patricia Jones, DrPH, MPH

Patricia Jones, DrPH, MPH

Lead, Common Metrics Initiative, Program Director

National Institutes of Health (NIH), United States

According to metrics experts, the first step in creating an effective measurement for a selected patient engagement effort is to determine how the metric will be used. Who needs the information, and what will resonate with them? In this session, approaches or models for developing patient engagement metrics in varying phases of the clinical research process will be examined. Strategies and planning for dissemination of the metrics and sharing the results within and outside of organizations will be discussed.

Learning Objective : At the conclusion of this session, participants should be able to:
Identify at least one key stakeholder who needs information about a selected patient engagement effort and the objective(s) for providing the information
Analyze the selected engagement process and intended outcomes to identify critical data that can drive measures
Outline a plan for sharing and optimizing use of metrics results within their organization

Speaker(s)

Linda B Sullivan, MBA

Metric Development Framework

Linda B Sullivan, MBA

Tufts Center For the Study of Drug Development, United States

Senior Fellow